Carregant...

BV6, an IAP antagonist, activates apoptosis and enhances radiosensitization of non-small cell lung carcinoma in vitro

INTRODUCTION: Defects in the apoptosis pathway limit the effectiveness of radiation in non-small cell lung cancer (NSCLC) therapy. BV6 is an antagonist of cIAP1 and XIAP, members of the inhibitors of apoptosis (IAP) family. We investigated the potential of BV6 to sensitize NSCLC cell lines to radiat...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Li, Wenyan, Li, Bo, Giacalone, Nicholas J., Torossian, Artour, Sun, Yunguang, Niu, Kathy, Lin-Tsai, Opal, Lu, Bo
Format: Artigo
Idioma:Inglês
Publicat: 2011
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3196825/
https://ncbi.nlm.nih.gov/pubmed/21760551
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JTO.0b013e318226b4a6
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!